It has been hurt by fierce competition in the US. Net profit for the April-June quarter fell to Rs 154 Cr from Rs 626 Cr in the previous year. Dr Reddy’s top priority for the year will be to fix quality control problems at three of its factories, which accounts for about 12% of its sales, after US regulators issued a warning letter highlighting quality compliance problems in November.

Dr Reddy's Labs quarterly profit slumps 75%

Leave a Reply

Your email address will not be published. Required fields are marked *